Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.45 -0.23%   SPY: 165.45 -0.29%
Discuss Index Tracked By  


  Track the *RXCAN Index  

Cancer Stocks (*RXCAN)

  Cancer Ideas       Cancer Performance       Cancer Community  
 
Popular long ideas:
Popular short ideas:
Top dividend plays:
Pro favorites:
DNDN, CTIC, GERN
DNDN, CTIC, BCRX
PDLI
ONXX, HSP, REGN
 
Index Description: These medical firms have significant exposure to cancer detection and treatment
     
Today:
1-month:
All-time:
+0.3%
-0.9%
+17.1%
vs S&P 500:
vs S&P 500:
vs S&P 500:
+0.6%
-5.7%
-2.7%
Data since: Jan-01-2008
 
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
$2.2B
17.9
0.2%
     
229 members Tracking
Share this Index on Facebook
Share this Index on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 
 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Alerts
 TELK $1.32 0.00 0.0% 1,622 6% $6.0M - 21% -82% No Alerts/News
 GNBT $0.04 +0.01 +26.6% 15,743,566 1173% $19.4M - 88% -66% 1 Alert (0 News) - View
 MSTX $0.69 +0.03 +4.9% 338,037 191% $30.4M - 53% -25% No Alerts/News
 CYCC $3.18 +0.19 +6.3% 965,040 370% $32.3M - 9% -61% 2 Alerts (0 News) - View
 DCTH $0.42 +0.01 +1.8% 797,752 23% $38.0M - 13% -83% No Alerts/News
 MELA $1.11 +0.03 +2.8% 395,095 77% $46.4M - 9% -75% 1 Alert (0 News) - View
 AEZS $2.03 -0.03 -1.5% 184,306 87% $52.1M - 19% -64% No Alerts/News
 CVM $0.25 -0.01 -1.9% 582,974 56% $79.1M - 22% -46% No Alerts/News
 BCRX $1.66 -0.02 -1.2% 619,284 34% $86.3M - 54% -66% 1 Alert (0 News) - View
 ONTY $1.95 -0.01 -0.5% 1,430,791 127% $112.1M - 14% -69% No Alerts/News
 MEIP $8.32 -0.10 -1.2% 24,353 32% $126.6M - 320% -37% No Alerts/News
 ENZN $3.16 +0.09 +2.9% 134,663 31% $134.2M - 7% -58% No Alerts/News
 AVEO $2.70 +0.04 +1.5% 2,342,505 67% $137.9M - 20% -81% 1 Alert (0 News) - View
 GERN $1.12 +0.02 +1.8% 546,524 82% $143.4M - 23% -63% No Alerts/News
 CTIC $1.22 -0.07 -5.4% 878,275 114% $145.3M - 20% -77% No Alerts/News
 CYTK $1.18 +0.05 +4.4% 830,574 49% $165.5M - 107% -19% No Alerts/News
 PGNX $4.06 +0.15 +3.8% 189,506 58% $199.5M - 188% -63% No Alerts/News
 PPHM $1.62 +0.04 +2.5% 2,555,089 98% $211.3M - 284% -71% No Alerts/News
 XOMA $4.13 +0.17 +4.3% 704,803 90% $328.2M - 84% -6% No Alerts/News
 GTXI $6.48 +0.18 +2.9% 1,045,180 246% $396.2M - 147% -9% No Alerts/News
 QLTI $7.89 -0.05 -0.6% 201,453 263% $401.2M - 25% -13% No Alerts/News
 DNDN $3.91 -0.04 -1.0% 2,226,359 46% $623.1M - 6% -51% No Alerts/News
 KERX $8.03 +0.15 +1.9% 1,632,547 70% $643.9M - 418% -20% No Alerts/News
 ARRY $5.66 -0.14 -2.4% 1,704,536 130% $676.7M - 89% -14% No Alerts/News
 EXEL $4.77 +0.19 +4.2% 1,167,025 72% $841.7M - 14% -31% No Alerts/News
 PDLI $8.35 +0.09 +1.1% 1,770,250 100% $1.1B 7.3% 35% -1% No Alerts/News
 ISIS $20.64 +0.25 +1.2% 1,105,351 61% $2.0B - 173% -10% No Alerts/News
 MYGN $32.19 -0.05 -0.2% 1,151,582 86% $2.5B - 46% -7% 1 Alert (0 News) - View
 ARIA $19.44 +1.01 +5.5% 4,705,446 152% $3.4B - 28% -23% 1 Alert (0 News) - View
 UTHR $67.61 -0.21 -0.3% 552,360 70% $3.4B - 62% -3% No Alerts/News
 SGEN $35.35 +0.20 +0.6% 711,361 89% $4.2B - 86% -9% No Alerts/News
 HSP $35.18 -0.22 -0.6% 683,396 50% $5.8B - 23% -7% No Alerts/News
 ONXX $96.20 +3.17 +3.4% 822,706 74% $6.7B - 133% -5% 1 Alert (0 News) - View
 VRTX $78.48 +0.05 +0.1% 1,663,549 49% $17.1B - 104% -10% No Alerts/News
 REGN $254.87 -7.55 -2.9% 848,580 52% $25.6B - 138% -10% No Alerts/News
Is this index incomplete or incorrect?
Got an idea for a new Index?
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering
CYCC  CYCCP  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 21, 04:13PM from (globenewswire.com)
BERKELEY HEIGHTS, N.J., May 21, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Dupilumab, a New Drug, May Help Some Asthmatics
REGN  SNY  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 21, 04:12PM from (www.nytimes.com)
The number of asthma attacks or other outbreaks of symptoms decreased by 87 percent in those getting the drug, Dupilumab,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
$307,000-a-year Vertex Drug: Billions in Sales?
VRTX  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 20, 12:50PM from (ycharts.com)
Here is a question that is likely to plague the pharmaceutical industry and patient advocacy groups for some time to come:  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
UK to Pilot Illumina Genetic Test for Breast, Ovarian Cancer
MYGN  ILMN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 20, 10:07AM from (www.bloomberg.com)
The U.K. is piloting a new genetic test developed by Illumina Inc. (ILMN) to help cancer patients and their doctors better  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
PGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 17, 05:43PM from (globenewswire.com)
TARRYTOWN, N.Y., May 17, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and Upcoming Deadline -- DCTH
DCTH  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 17, 05:43PM from (globenewswire.com)
NEW YORK, May 17, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
VRTX  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 17, 08:30AM from (www.businesswire.com)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it has called for redemption of its outstanding $400.0  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mid-Morning Market Update: Housing Starts Plummet, Initial Jobless Claims Rise
AMD  CSCO  HALO  DRYS  ONTY  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 16, 10:51AM from (www.benzinga.com)
Following the market opening Wednesday, the Dow traded down 0.12 percent to 15,257.00, while the NASDAQ rose 0.15 percent  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top New Biotech Ideas from PropThink
CELG  REGN  CBST  VPHM  ONXX  AVEO  MAKO  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com)
The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
ARRY  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 16, 02:18AM from (www.bloomberg.com)
AstraZeneca Plc (AZN) will move three experimental cancer treatments into late-stage development as generic competition for its best-selling drugs intensifies.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Summary of Jana Partners 13F: Aetna, Expedia and Kinder Morgan All Raised Among Others
AIG  BA  KO  SVU  FNP  BIG  ODP  WM  BMC  SYMC  IACI  CPRT  TK  AGU  OPK  VRSN  IRM  CVG  AXL  NFLX  VC  AET  HSP  ASH  ROC  EXPE  LYV  SE  KAR  DTV  LINTA  QEP  SEMG  KMI  GRPN  ZNGA  TRIP  ADT  FANG  LMCA  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 15, 03:24PM from (www.benzinga.com)
Barry Rosenstein's JANA Partners released its 13F for Q1 Wednesday.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Company That Sells Angelina Jolie’s Blood Test
MYGN  MON  
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 15, 03:18PM from (ycharts.com)
Shares of Myriad Genetics (MYGN) spiked higher yesterday to hit their highest levels on record since mid-2009, as seen in  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
What We're Reading ~ Analytical Links 5/15/13
VZ  VOD  DLTR  HSP  FLT  
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 15, 01:05PM from (www.marketfolly.com)
Meb Faber's new book: Shareholder Yield [Meb Faber]



Explanation of Tepper's chart: Equity risk premium is high (this is bullish) [The Big Picture]
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Dendreon Gets Prostate Cancer Competition for Provenge from Bayer’s Xofigo
DNDN  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 11:15AM from (247wallst.com)
Dendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Deutsche Bank Firm on Biotech Stocks to Buy
AMGN  CELG  REGN  BIIB  VRTX  GILD  ALXN  ONXX  DB  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 08:10AM from (247wallst.com)
Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mast Therapeutics Reports First Quarter 2013 Financial Results
MSTX  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 15, 08:00AM

SAN DIEGO, May 15, 2013 /PRNewswire/ -- Mast Therapeutics,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Roche Wins FDA Approval for Test to Target Lung Cancer
MYGN  QGEN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 14, 05:43PM from (www.bloomberg.com)
Roche Holding AG (ROG), the world’s biggest maker of cancer drugs, won U.S. approval to sell a gene mutation test that  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics, Angelina Jolie, and Genomics in Focus
MYGN  GHDX  ROSG  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 14, 01:58PM from (247wallst.com)
Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics to Present at the Bank of America Merrill Lynch Health Care Conference
MYGN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 07:13AM from (globenewswire.com)
SALT LAKE CITY, May 14, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 156



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
tickerspy Indexes use a "net asset value" calculation. The components are equally weighted at the inception of the Index (typically 1/1/2008) and over time as some stocks go up and others go down, the relative weights of the components shift accordingly.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Cancer Stocks Index (*RXCAN).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments